"It's a very good introduction to anti-inflammatory meals," said a staff member at one of our clinics. "I borrowed it for my sister who has MS, but I ended up following the recipes myself. The grocery lists make it so easy to plan ahead and everything tasted great."
Feel free to drop by the Neuro-Patient Resource Centre (room 354) to borrow the book!
The Neuro-Patient Resource has created reading lists for each of the Neuro's outpatient clinics. Come borrow the books in room 354!
Download the PDF version of a reading list below:
A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.
"The Multiple Sclerosis Society of Canada is pleased to announce a new partnership with SPIRIT Club. SPIRIT Club is an online gym where with a membership you can access all of their live and recorded virtual wellness, exercise and fitness programming (e.g., yoga, Zumba, fitness, meditation, nutrition, etc.). The MS Society has secured a group membership with SPIRIT Club and by registering with us you will receive a link that will allow you to create a free membership account with SPIRIT Club, giving you access to all of their virtual programming.
Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers. The study, published in the International Journal of MS Care, examined the differential between measurement tools for clinical walking capacity and real-world performance.
May is Multiple Sclerosis (MS) Month. Laboratory and clinical studies related to MS involve about 50 members of The Neuro’s staff. They study the disease in all its aspects and at every stage with the help of the most advanced brain imaging technology and the latest cell biology techniques.
By Ross Neitz, University of Alberta
A discovery led by scientists at the University of Alberta and McGill University is providing hope of a new therapeutic target in Multiple Sclerosis (MS) patients, which could one day be used to prevent the symptoms and progression of the disease.
The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada’s first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.
Drug shown to reduce new attacks/symptom progression in some patients
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.
A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.
The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.
3D depth-sensing camera shown to measure walking difficulties
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.
The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.
3D depth-sensing camera shown to measure walking difficulties
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.
The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.
Multiple sclerosis treatment and research has long been a focus at the Montreal Neurological Institute and Hospital, known simply as The Neuro, an illustrious member of McGill University and the McGill University Health Centre. Indeed, The Neuro introduced Canada’s first MS clinic. The clinic’s highly specialized staff employs the latest research data and treatment methods in a clinical atmosphere of innovation and progress.
A new study led by researchers at the Montreal Neurological Institute and Hospital of McGill University and the MUHC, gets closer to identifying the mechanisms responsible for multiple sclerosis and makes headway in the search for better treatments.
Low levels of vitamin D significantly increase the risk of developing multiple sclerosis (MS), according to a study led by Dr. Brent Richards of the Lady Davis Institute at the Jewish General Hospital, and published in PLOS Medicine. This finding, the result of a sophisticated Mendelian randomization analysis, confirms a long-standing hypothesis that low vitamin D is strongly associated with an increased susceptibility to MS. This connection is independent of other factors associated with low vitamin D levels, such as obesity.
